We further tested whether the tumor-suppressive effect is p53 dependent by comparing the effect of Usp7 depletion in our CRISPR-engineered HCT116 cell line carrying an additional APC mutation (HCT116 APCCRISPR) in both p53 WT and null backgrounds. This evidence concerns the gene TP53 and neoplasm.